Home / Stock ratings / PRGO
Stock rating · Pharmaceutical Preparations
Perrigo Company PLC (PRGO) Stock Rating & Analysis
As of October 13, 2026, MELANY rates Perrigo Company PLC 80 out of 100 (Highest Conviction). Its highest factor score is catalyst setup at 94, and its lowest is business quality at 30.
MELANY ratingRated 2026-10-13PRGO · composite score
About Perrigo Company PLC
Perrigo is among the largest consumer health companies in the world. Since 2018 it has divested its animal health and generic pharmaceuticals businesses to focus solely on consumer self-care. In North America (two-thirds of total sales), its mix centers on private-label consumer health goods sold to major retailers such as Walmart, Amazon, Costco, and CVS. In Europe, Australia, and parts of Asia it mainly sells national brands including Compeed, Solpadeine, Coldrex, and ellaOne.
Rating as of 2026-10-13 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why PRGO scores 80/100
PRGO's 8 factor scores run from 30 to 94, and 4 of them sit above its composite of 80. Here is how PRGO breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- PEG ratio 1.14 (< 1 = undervalued)
- FCF yield 20.6%
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- Price +9.9% above 50-day MA
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 3 of last 4 quarters
- Avg EPS beat +20%
- Earnings in 22 days (strong beat history)
What Wall Street price targets and revisions are signalling.
- Institutional net buying +5.3%
Near-term events that could move the stock.
- Earnings in 22 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How PRGO compares
As of October 14, 2026, Perrigo Company PLC ranks 1st of the 15 companies with a MELANY rating page in its SEC industry group (Pharmaceutical Preparations), where the average score is 69.
Key risks for PRGO
- Short interest 27% of float, high volatility risk on news
- No positive trailing earnings, valuation cannot be anchored to current P/E
Sector and theme context
Perrigo Company PLC sits in the Healthcare sector theme, which MELANY currently rates 62/100 for strength. Theme strength feeds PRGO's momentum and catalyst factors above.
PRGO trade plan (Pro)
MELANY has a full position plan for Perrigo Company PLC: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates PRGO
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Perrigo Company PLC's 80/100 reflects speculative factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about PRGO
Is Perrigo Company PLC (PRGO) a buy?
As of 2026-10-13, MELANY rated Perrigo Company PLC Highest Conviction with a composite score of 80/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Perrigo Company PLC's MELANY score?
Perrigo Company PLC (PRGO) has a MELANY composite score of 80/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the PRGO stock rating calculated?
MELANY scores PRGO from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Perrigo Company PLC stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Perrigo Company PLC (PRGO) Highest Conviction with a composite of 80/100 as of 2026-10-13. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the PRGO stock price forecast?
MELANY does not publish price targets or forecasts for PRGO. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 80/100 across eight factors for Perrigo Company PLC, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is PRGO stock overvalued or undervalued?
MELANY's valuation factor currently reads 92/100 for Perrigo Company PLC, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives PRGO's read.
What price should I buy PRGO at?
Rather than chasing the current price, MELANY computes a smart entry zone for PRGO: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying PRGO stock?
The top risks MELANY currently flags for Perrigo Company PLC: Short interest 27% of float, high volatility risk on news; No positive trailing earnings, valuation cannot be anchored to current P/E. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Perrigo Company PLC a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 30/100 for Perrigo Company PLC, and earnings track record, at 88/100. The 80/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will PRGO stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 85/100 for PRGO right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this PRGO rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-13. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores PRGO continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, PRGO included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.